AllianceBernstein’s Aktis Oncology AKTS Stock Holding History
Bought
Maintained
Sold
Other funds holding AKTS
AllianceBernstein's AKTS Position: Q3 2026 in Review
AllianceBernstein opened a new position in Aktis Oncology (AKTS) in Q3 2026: 17,900 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings.
122 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.
- AllianceBernstein held 17,900 shares of Aktis Oncology worth $349K as of Q3 2026.
- Aktis Oncology was a new AllianceBernstein position in Q3 2026.
- Aktis Oncology made up ﹤0.01% of AllianceBernstein's portfolio in Q3 2026, its #2880 holding.
- 122 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.
Based on AllianceBernstein's 13F filing for Q3 2026, filed 16 Nov 2026.